Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002358 | A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV | PHASE3 | COMPLETED | - | — | — | - | - | Oct 2, 2007 | 1 | United States |
| NCT00000953 | Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients | PHASE2 | COMPLETED | 180 | — | — | - | - | Mar 1, 2011 | 44 | United States |
| Name | Type | Description |
|---|---|---|
| Sorivudine | DRUG | - |
| Acyclovir | DRUG | - |
Inclusion Criteria Patients must have: * HIV infection. * Cutaneous, visceral, or ocular varicella-zoster viral infection. * Refractory or intolerant to acyclovir or foscarnet therapy. * Consent of parent or guardian. Exclusion Criteria Co-existing Condition: Patients with the following symptom...